Drug Shortage Report for PERPHENAZINE
| Report ID | 127429 |
| Drug Identification Number | 00335118 |
| Brand name | PERPHENAZINE |
| Common or Proper name | Perphenazine |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PERPHENAZINE |
| Strength(s) | 8MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100BTL |
| ATC code | N05AB |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-10-28 |
| Estimated end date | 2020-11-16 |
| Actual end date | 2020-11-17 |
| Shortage status | Resolved |
| Updated date | 2021-02-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-10-28 | English | Compare |
| v2 | 2020-10-28 | French | Compare |
| v3 | 2020-10-29 | English | Compare |
| v4 | 2021-02-10 | English | Compare |
| v5 | 2021-02-10 | French | Compare |
Showing 1 to 5 of 5